
Journal of Nanobiotechnology, Journal Year: 2025, Volume and Issue: 23(1)
Published: April 7, 2025
Language: Английский
Journal of Nanobiotechnology, Journal Year: 2025, Volume and Issue: 23(1)
Published: April 7, 2025
Language: Английский
Advanced Science, Journal Year: 2024, Volume and Issue: 12(2)
Published: Nov. 13, 2024
Helicobacter pylori (H. pylori) is a primary pathogen associated with gastrointestinal diseases, including gastric cancer. The increase in resistance to antibiotics, along the adverse effects caused by complicated medication protocols, has made eradication of H. more formidable challenge, necessitating alternative therapeutics. Herein, targeted nanoplatform reported based on sonodynamic therapy, chitosan-conjugated fucose loaded indocyanine green (ICG@FCS). It penetrates mucosa and homes through dual targeting mechanisms: molecular via physical ultrasound. Upon ultrasound activation, it generates singlet oxygen, effectively attacking planktonic bacteria, disrupting biofilms, facilitating clearance intracellular bacteria promoting autophagy, multidrug-resistant strains. ICG@FCS minimally affects gut microbiota aids repair. holistic integrative therapy strategy proposed that targets while preserving health. This emphasizes importance maintaining patient health eradicating pathogen. advancement set refine comprehensive antibacterial approach, offering promising horizon ongoing battle against antibiotic effective cancer prevention strategies.
Language: Английский
Citations
5Materials Today Bio, Journal Year: 2025, Volume and Issue: 30, P. 101445 - 101445
Published: Jan. 5, 2025
Chemotherapy is widely recognized as a highly efficacious modality for cancer treatment, involving the administration of chemotherapeutic agents to target and eradicate tumor cells. Currently, oral stands prevailing utilized method delivering chemotherapy drugs. However, majority anti-tumor medications exhibit limited solubility permeability, poor stability in harsh gastrointestinal environments, thereby impeding their therapeutic efficacy chemotherapy. Therefore, more micro-nano drug delivery carriers have been developed used effectively deliver anti-cancer drugs, which can overcome physiological barriers, facilitate administration, ultimately improve efficacy. In this paper, we first discuss effects various biological barriers on approach. Then, development based biomedical components, such micelles, dendrimers, hydrogels, liposomes, inorganic nanoparticles, etc. were introduced. Finally, current dilemma potential clinical treatment discussed. The primary objective review introduce methods serve point reference advancement novel carriers, with ultimate goal informing future applications.
Language: Английский
Citations
0Nano Biomedicine and Engineering, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 1, 2025
Language: Английский
Citations
0Research Square (Research Square), Journal Year: 2025, Volume and Issue: unknown
Published: Feb. 10, 2025
Language: Английский
Citations
0Journal of Nanobiotechnology, Journal Year: 2025, Volume and Issue: 23(1)
Published: April 7, 2025
Language: Английский
Citations
0